ArticlePharmaceutical research2023

Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions.

Jessica Chu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.